{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:05:29Z","timestamp":1765814729785,"version":"3.48.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    Brain metastasis (BRM) of pancreatic ductal adenocarcinoma (PDAC) is rare. The clinicopathological characteristics of BRM have not been defined. We reviewed the clinicopathologic and molecular features of 18 PDAC patients who underwent resection of primary tumor (RPT) and developed BRM, along with 2 patients who had BRM resection without RPT and compared with 679 patients without BRM who received neoadjuvant therapy (NAT) and pancreatectomy. There were 11 males and 9 females (median age: 60.7\u00a0y). The median intervals to BRM were 47.0, 44.4, and 31.6 months from dates of diagnosis, surgery, and first metastasis to other sites, respectively. Five patients underwent resection for BRM and showed unique cystic papillary growth patterns with detached cell clusters. All BRMs had mutant p53 staining, 4 had retained SMAD4, and 3 were focally positive for CK17. Among 18 patients who underwent RPT, 12 received NAT. Patients with BRMs have lower tumor stage (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001) and better tumor response (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.01) at RPT. The median overall survival (OS) for 18 patients with BRM after RPT was 62.3 months compared with 42.4 months for those without BRM (n=679,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.59). The median survival was 3.3 months from BRM diagnosis for all patients and 6.9 months for 5 patients who underwent brain surgery. In summary, BRM represents a late event in PDAC patients, occurs after patients developed metastasis to other organs, and has distinct cystic papillary growth pattern. The prognosis for patients who underwent RPT and developed BRM is similar to those who underwent RPT without BRM.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002470","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:00:31Z","timestamp":1757653231000},"page":"74-83","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathologic Characteristics of Brain Metastasis of Pancreatic Ductal Adenocarcinoma"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8632-5513","authenticated-orcid":false,"given":"Shaimaa","family":"Elzamly","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouaz","family":"Alsawas","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud M.G.","family":"Yousef","sequence":"additional","affiliation":[{"name":"Gastrointestinal Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Gastrointestinal Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew HG.","family":"Katz","sequence":"additional","affiliation":[{"name":"Surgical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura R.","family":"Prakash","sequence":"additional","affiliation":[{"name":"Surgical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[{"name":"Gastrointestinal Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziang","family":"Li","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Wolff","sequence":"additional","affiliation":[{"name":"Gastrointestinal Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anirban","family":"Maitra","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huamin","family":"Wang","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"R1-20251215","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20251215","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N Engl J Med"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4251\/wjgo.v12.i2.173","article-title":"Pancreatic ductal adenocarcinoma: treatment hurdles, tumor microenvironment and immunotherapy","volume":"12","author":"Sarantis","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"R4-20251215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1024337020884","article-title":"Nervous system involvement by pancreatic cancer","volume":"63","author":"Park","year":"2003","journal-title":"J Neurooncol"},{"key":"R5-20251215","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1002\/cncr.25940","article-title":"Gastrointestinal cancer and brain metastasis: a rare and ominous sign","volume":"117","author":"Go","year":"2011","journal-title":"Cancer"},{"key":"R6-20251215","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/cam4.459","article-title":"Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer","volume":"4","author":"Peixoto","year":"2015","journal-title":"Cancer Med"},{"key":"R7-20251215","first-page":"584","article-title":"Carcinoma of the pancreas and periampullary structures. Pattern of metastasis at autopsy","volume":"108","author":"Lee","year":"1984","journal-title":"Arch Pathol Lab Med"},{"key":"R8-20251215","first-page":"e315","article-title":"Brain Metastases in pancreatic ductal adenocarcinoma: assessment of molecular genotype-phenotype features-an entity with an increasing incidence?","volume":"17","author":"Jordan","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"R9-20251215","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.dld.2003.10.019","article-title":"Pancreatic carcinoma with brain metastases: case report and literature review","volume":"36","author":"El Kamar","year":"2004","journal-title":"Dig Liver Dis"},{"key":"R10-20251215","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2176\/nmc.30.476","article-title":"Brain and skull metastases of hepatic or pancreatic cancer--report of six cases","volume":"30","author":"Kuratsu","year":"1990","journal-title":"Neurol Med Chir"},{"key":"R11-20251215","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1477-7819-10-138","article-title":"Oncocytic-type intraductal papillary mucinous neoplasm (IPMN)-derived invasive oncocytic pancreatic carcinoma with brain metastasis\u2014a case report","volume":"10","author":"Chiang","year":"2012","journal-title":"World J Surg Oncol"},{"key":"R12-20251215","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000092693","article-title":"Cerebellar metastasis from pancreatic adenocarcinoma. A case report","volume":"6","author":"Caricato","year":"2006","journal-title":"Pancreatology"},{"key":"R13-20251215","first-page":"4599","article-title":"Long-term survival following resection of brain metastases from pancreatic cancer","volume":"31","author":"Lemke","year":"2011","journal-title":"Anticancer Res"},{"key":"R14-20251215","first-page":"2433","article-title":"A case of postoperative brain metastasis originated from pancreatic cancer which was successfully treated by resection and postoperative irradiation","volume":"36","author":"Matsumura","year":"2009","journal-title":"Gan To Kagaku Ryoho"},{"key":"R15-20251215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/1793-5482.151507","article-title":"Brain metastasis from pancreatic cancer: a case report and literature review","volume":"10","author":"Matsumoto","year":"2015","journal-title":"Asian J Neurosurg"},{"key":"R16-20251215","first-page":"e27578","article-title":"A rare case of brain metastases in an elderly patient with primary pancreatic cancer","volume":"14","author":"Rajpal","year":"2022","journal-title":"Cureus"},{"key":"R17-20251215","doi-asserted-by":"crossref","first-page":"bcr0820080620","DOI":"10.1136\/bcr.08.2008.0620","article-title":"Brain metastases from pancreatic adenocarcinoma","volume":"2009","author":"Zaanan","year":"2009","journal-title":"BMJ Case Rep"},{"key":"R18-20251215","first-page":"90","article-title":"An extremely rare case of pancreatic cancer presenting with leptomeningeal carcinomatosis and synchronous intraparenchymal brain metastasis","volume":"6","author":"Rao","year":"2013","journal-title":"Gastrointest Cancer Res"},{"key":"R19-20251215","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.wneu.2018.12.036","article-title":"Multiple brain metastases from pancreatic adenocarcinoma manifesting with simultaneous intratumoral hemorrhages","volume":"123","author":"Matsuo","year":"2019","journal-title":"World Neurosurg"},{"key":"R20-20251215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12876-020-01587-3","article-title":"Simultaneous brain and lung metastases of pancreatic ductal adenocarcinoma after curative pancreatectomy: a case report and literature review","volume":"21","author":"Oka","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"R21-20251215","doi-asserted-by":"crossref","first-page":"e14227","DOI":"10.1097\/MD.0000000000014227","article-title":"Brain metastasis in pancreatic cancer: two case reports","volume":"98","author":"Sasaki","year":"2019","journal-title":"Medicine"},{"key":"R22-20251215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12029-014-9667-y","article-title":"CNS involvement in pancreatic adenocarcinoma: a report of eight cases from the Johns Hopkins Hospital and review of literature","volume":"46","author":"Kumar","year":"2015","journal-title":"J Gastrointest Cancer"},{"key":"R23-20251215","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s10620-008-0531-4","article-title":"Octreotide uptake in intracranial metastasis of pancreatic ductal adenocarcinoma origin in a patient with a prolonged clinical course","volume":"54","author":"Marepaily","year":"2009","journal-title":"Dig Dis Sci"},{"key":"R25-20251215","doi-asserted-by":"crossref","first-page":"oyae182","DOI":"10.1093\/oncolo\/oyae182","article-title":"Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma","volume":"30","author":"Yousef","year":"2025","journal-title":"Oncologist"},{"key":"R26-20251215","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/cncr.26651","article-title":"Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome","volume":"118","author":"Chatterjee","year":"2012","journal-title":"Cancer"},{"key":"R27-20251215","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/PAS.0000000000000738","article-title":"Validation of a proposed tumor regression grading scheme for pancreatic ductal adenocarcinoma after neoadjuvant therapy as a prognostic indicator for survival","volume":"40","author":"Lee","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R28-20251215","doi-asserted-by":"crossref","first-page":"838","DOI":"10.5858\/arpa.2019-0477-RA","article-title":"Pathology of treated pancreatic ductal adenocarcinoma and its clinical implications","volume":"144","author":"Nagaria","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"R29-20251215","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.3390\/cancers15092608","article-title":"Prognosticators for patients with pancreatic ductal adenocarcinoma who received neoadjuvant FOLFIRINOX or gemcitabine\/nab-paclitaxel therapy and pancreatectomy","volume":"15","author":"Tong","year":"2023","journal-title":"Cancers"},{"key":"R30-20251215","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/PAS.0b013e318249ce1c","article-title":"Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma","volume":"36","author":"Kelly","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R31-20251215","doi-asserted-by":"crossref","first-page":"11239","DOI":"10.1038\/s41598-019-47519-4","article-title":"Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer","volume":"9","author":"Roa-Pena","year":"2019","journal-title":"Sci Rep"},{"key":"R32-20251215","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1200\/JCO.2008.17.7188","article-title":"DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer","volume":"27","author":"Iacobuzio-Donahue","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:02:33Z","timestamp":1765814553000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002470","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"type":"print","value":"0147-5185"},{"type":"electronic","value":"1532-0979"}],"subject":[],"published":{"date-parts":[[2025,9,15]]}}}